Literature DB >> 20164415

MyD88 adaptor-like D96N is a naturally occurring loss-of-function variant of TIRAP.

Julie George1, Andriy V Kubarenko, Anna Rautanen, Tara C Mills, Elif Colak, Tore Kempf, Adrian V S Hill, Alexandra Nieters, Alexander N R Weber.   

Abstract

Signals elicited by TLRs following the detection of microbes are integrated and diversified by a group of four cytoplasmic adaptor molecules featuring an evolutionarily conserved Toll/IL-1R signaling domain. Single nucleotide polymorphisms (SNPs) in TLRs and their adaptor molecules have been shown to influence susceptibility to a range of infectious and other diseases. The adaptor MyD88 adaptor-like (Mal)/Toll/IL-1R-containing adaptor protein is involved in TLR2 and 4 signal transduction by recruiting another adaptor molecule, MyD88, to the plasma membrane. In this study, we used naturally occurring variants of Mal as tools to study the molecular biology of Mal in more detail in cellular model systems and to thereby identify functionally interesting variants whose corresponding nonsynonymous SNPs might be of further epidemiological interest. Of seven reported variants for Mal, we found Mal D96N associated with reduced NF-kappaB signaling and cytokine production after overexpression in HEK293 and Huh-7 cells. The D96N mutation prevented Mal from recruiting its signaling partner MyD88 to the plasma membrane and altered posttranslational modification of Mal. These findings led us to investigate the frequency of heterozygosity for the corresponding SNP rs8177400 in a Caucasian case-control study on the etiology of lymphoma, a disease in which TLRs have been implicated. Although rs8177400 did not modify lymphoma risk in general, its frequency of heterozygosity was accurately determined to 0.97%. Our data add rs8177400 (D96N) to the list of functionally important variants of Mal and warrant further research into its immunological, epidemiological, and diagnostic relevance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20164415     DOI: 10.4049/jimmunol.0901156

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Structural basis of TIR-domain-assembly formation in MAL- and MyD88-dependent TLR4 signaling.

Authors:  Thomas Ve; Parimala R Vajjhala; Andrew Hedger; Tristan Croll; Frank DiMaio; Shane Horsefield; Xiong Yu; Peter Lavrencic; Zahid Hassan; Garry P Morgan; Ashley Mansell; Mehdi Mobli; Ailis O'Carroll; Brieuc Chauvin; Yann Gambin; Emma Sierecki; Michael J Landsberg; Katryn J Stacey; Edward H Egelman; Bostjan Kobe
Journal:  Nat Struct Mol Biol       Date:  2017-07-31       Impact factor: 15.369

2.  Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells.

Authors:  Jelena Knezević; Dinko Pavlinić; William A Rose; Cynthia A Leifer; Kreso Bendelja; Jelka Gabrilovac; Marijo Parcina; Gordan Lauc; Andriy V Kubarenko; Branka Petricevic; Damir Vrbanec; Ljiljana Bulat-Kardum; Isabelle Bekeredjian-Ding; Jasminka Pavelić; Zlatko Dembić; Alexander N R Weber
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

3.  A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.

Authors:  Andriy V Kubarenko; Satish Ranjan; Anna Rautanen; Tara C Mills; Sunny Wong; Fredrik Vannberg; Michael Neumaier; Isabelle Bekeredjian-Ding; Adrian V S Hill; Parviz Ahmad-Nejad; Alexander N R Weber
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

4.  Identification of binding sites for myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 in MyD88 adapter-like (Mal).

Authors:  Celia Bovijn; Anne-Sophie Desmet; Isabel Uyttendaele; Tim Van Acker; Jan Tavernier; Frank Peelman
Journal:  J Biol Chem       Date:  2013-03-04       Impact factor: 5.157

5.  Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly.

Authors:  Julie George; Precious G Motshwene; Hui Wang; Andriy V Kubarenko; Anna Rautanen; Tara C Mills; Adrian V S Hill; Nicholas J Gay; Alexander N R Weber
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

6.  Structural insights into TIR domain specificity of the bridging adaptor Mal in TLR4 signaling.

Authors:  Zhijie Lin; Jing Lu; Weihong Zhou; Yuequan Shen
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

7.  TIRAP Rs8177376, Rs611953, Rs3802814, and Rs8177374 Polymorphisms and Their Association with Cervical Cancer Phenotype and Prognosis.

Authors:  Justina Bekampytė; Aistė Savukaitytė; Agnė Bartnykaitė; Rasa Ugenskienė; Eglė Žilienė; Arturas Inčiūra; Elona Juozaitytė
Journal:  Genes (Basel)       Date:  2022-07-29       Impact factor: 4.141

8.  RNA and imidazoquinolines are sensed by distinct TLR7/8 ectodomain sites resulting in functionally disparate signaling events.

Authors:  Elif Colak; Alasdair Leslie; Kieran Zausmer; Elham Khatamzas; Andriy V Kubarenko; Tica Pichulik; Sascha N Klimosch; Alice Mayer; Owen Siggs; Andreas Hector; Roman Fischer; Benedikt Klesser; Anna Rautanen; Martin Frank; Adrian V S Hill; Bénédicte Manoury; Bruce Beutler; Dominik Hartl; Alison Simmons; Alexander N R Weber
Journal:  J Immunol       Date:  2014-05-09       Impact factor: 5.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.